NFKB1 and liver cancer: The curcumin antiproliferative effect was confirmed by Nan et al., who reported marked induction apoptosis of liver cancer cells, reversed the drug resistance of paclitaxel through inhibiting NF-κB pathway stimulated Lin28B expression (149).